Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

4Q Pharma Results Preview, Part 3: Gilead, GSK, Sanofi, Allergan, Shire, Bayer, Valeant

Feb 03 2017

• By Scrip Team

Related Content

‘Between A Rock And A Hard Place,’ Court Issues Injunction To Halt Praluent Sales

Jan 06 2017

GSK US Pharma President Jack Bailey On A “Dynamic” 2017

Jan 23 2017

Gilead Plays Up Its Strength As Market Awaits Business Development Moves

Jan 10 2017

J&J’s $30bn For Actelion Buys Immediate And Longer-Term Value

Jan 26 2017

J.P. Morgan Notebook Day 2: Bristol Humbled By Competition, Sanofi’s Sarilumab Ready For Review, Justifying Spinraza’s Price And More

Jan 11 2017

Debt-laden Valeant Sells Its Assets, More Divestments Likely

Jan 10 2017

GSK Management Shake Up Ahead Of New CEO Sees Hussain Out, AZ's Miels In

Jan 19 2017

Pharma ExtrapolaTable: The 2016 Top 20

Jan 13 2017

Intercept’s NASH Phase III Enrolling Slowly; Gilead Could Gain Ground

Jan 13 2017

Trump Throws Pharma A Curve Ball On The Third Day Of J.P. Morgan

Jan 12 2017

Deal Watch: J.P. Morgan Brings Continued Brisk Pace Of Transactions

Jan 12 2017

VENUS II Paves Way For Allergan's Ulipristal NDA In Uterine Fibroids

Jan 18 2017

Sanofi CEO Upbeat Despite Medivation M&A Miss, Sarilumab Diss

Oct 31 2016

Allergan Adds Accretive Aesthetics Assets In $2.9bn LifeCell Acquisition

Dec 21 2016

Shire's Ornskov: The Modest Pediatrician With Fierce Corporate Ambition

Dec 21 2016

Is Bayer Making A Mistake With Monsanto When Pharma Is Its Leading Business?

Jul 27 2016

Shire Plays Up Xiidra Launch, Downplays Missed Sales Expectations

Nov 01 2016

Is Gilead Vulnerable to ViiV As It Nears End Of HIV R&D Activity?

Nov 03 2016

Allergan’s Namesake Acquisition Looks Well-Timed As Established Brands Falter

Nov 03 2016

GSK’s New CEO Designate Walmsley Fortifies Volume Growth Strategy

Sep 20 2016

Bayer Reiterates Pharma Commitment Post-Monsanto, Plays Up Pipeline

Sep 20 2016

Amgen’s Repatha Passes CVOT Test, But Contribution To 2017 Sales Growth Unclear

Feb 03 2017

CVS Expands Formulary Exclusions In 2017, Express Scripts’ Tally Unchanged

Aug 03 2016

Related Companies

Gilead Sciences, Inc.

AbbVie Inc.

Merck & Co., Inc.

GSK plc

AstraZeneca PLC

Sanofi

Regeneron Pharmaceuticals, Inc.

Amgen, Inc.

Eli Lilly and Company

Sanofi Genzyme

Medivation, Inc.

Allergan plc

Takeda Pharmaceutical Co. Ltd.

Lysosomal Therapeutics Inc.

Assembly Biosciences, Inc.

Allergan, Inc.

Baxalta Incorporated

Bayer AG

Pfizer Inc.

Bausch Health Companies Inc.

Additional Topics

Sales & Earnings Companies Deals M & A Commercial BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window